Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

出版年份 2018 全文链接

标题

作者

关键词

Pegylation, Refractory NSCLC, Third-line therapy, Topoisomerase I inhibitor

出版物

Clinical Lung Cancer

Volume 19, Issue 2, Pages 157-162

出版商

Elsevier BV

发表日期

2017-10-20

DOI

10.1016/j.cllc.2017.10.007

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now